ArticleACS medicinal chemistry letters2025

Novel Azaindazole Derivatives as HCN2 Modulators for Treating Central Nervous System and Psychiatric Disorders, Namely, Schizophrenia, Autism, and Mood Disorders.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.